Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 27781378)

Published in Pediatr Transplant on October 26, 2016

Authors

Audrey H Lau1,2, Matthew J Vitalone2, Kelly Haas1, Todd Shawler2, Carlos O Esquivel2, William E Berquist1, Olivia M Martinez2,3, Ricardo O Castillo1, Sheri M Krams2,3

Author Affiliations

1: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford, CA, USA.
2: Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
3: Stanford Immunology, Stanford University School of Medicine, Stanford, CA, USA.

Articles cited by this

Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science (2011) 15.45

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41

Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest (2008) 2.73

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med (2013) 2.39

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology (2013) 1.93

High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation (2008) 1.85

Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69

Automated identification of stratifying signatures in cellular subpopulations. Proc Natl Acad Sci U S A (2014) 1.61

CD5 instructs extrathymic regulatory T cell development in response to self and tolerizing antigens. Immunity (2015) 1.58

Characterization of γδ T cell subsets in organ transplantation. Transpl Int (2010) 1.57

Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57

The pattern of late mortality in liver transplant recipients in the United Kingdom. Transplantation (2011) 1.57

Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant (2004) 1.40

Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33

An appraisal of tolerance in liver transplantation. Am J Transplant (2006) 1.32

Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation (1995) 1.14

Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukoc Biol (2006) 1.09

An analysis of late deaths after liver transplantation. Transplantation (1996) 1.06

Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant (2008) 0.95

Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance. J Am Soc Nephrol (2015) 0.91

Chronic ethanol exposure affects in vivo migration of hepatic dendritic cells to secondary lymphoid tissue. Hum Immunol (2007) 0.90

A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am J Transplant (2012) 0.88

Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation (2009) 0.87

Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol (1994) 0.85

The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation (1996) 0.85

Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo. FASEB J (2014) 0.84

Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression. Pediatr Transplant (2013) 0.83

Adverse effects of immunosuppression in pediatric solid organ transplantation. Paediatr Drugs (2010) 0.83

Markers of acute rejection and graft acceptance in liver transplantation. World J Gastroenterol (2015) 0.81

Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective. Transpl Int (2008) 0.81

Changes in natural killer cell subsets in pediatric liver transplant recipients. Pediatr Transplant (2012) 0.78